aluates Reports

$ 0.0

Automative

Global Crohn’s Disease Drug Market Research Report 2024

Published Date: March 2024

Report Code: QYRE-Auto-10C8717

Global Crohn s Disease Drug Market Insights and Forecast to 2028

BUY CHAPTERS

Global Crohn’s Disease Drug Market Research Report 2024

Code: QYRE-Auto-10C8717

Report

March 2024

Pages:84

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Takeda Pharmaceuticals

Crohn’s Disease Drug Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Crohn’s Disease Drug Market

The global Crohn’s Disease Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Crohn’s Disease Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Crohn’s Disease Drug.

Report Scope

The Crohn’s Disease Drug market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Crohn’s Disease Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Crohn’s Disease Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Crohn’s Disease Drug Market Report

Report Metric	Details
Report Name	Crohn’s Disease Drug Market
CAGR	5%
Segment by Type	Aminosalicylates (5-ASA) Corticosteroids Immunomodulators Antibiotics
Segment by Application	Achieving Remission (The Absence Of Symptoms) Maintaining Remission (Prevention Of Flare-Ups) Pediatric Crohn'S Disease
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	AbbVie, Janssen Biotech, Amgen, Tillotts Pharma, Takeda Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Crohn’s Disease Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Crohn’s Disease Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Crohn’s Disease Drug Market report?

Ans: The main players in the Crohn’s Disease Drug Market are AbbVie, Janssen Biotech, Amgen, Tillotts Pharma, Takeda Pharmaceuticals

What are the Application segmentation covered in the Crohn’s Disease Drug Market report?

Ans: The Applications covered in the Crohn’s Disease Drug Market report are Achieving Remission (The Absence Of Symptoms), Maintaining Remission (Prevention Of Flare-Ups), Pediatric Crohn'S Disease

What are the Type segmentation covered in the Crohn’s Disease Drug Market report?

Ans: The Types covered in the Crohn’s Disease Drug Market report are Aminosalicylates (5-ASA), Corticosteroids, Immunomodulators, Antibiotics

1 Crohn’s Disease Drug Market Overview

1.1 Product Overview and Scope of Crohn’s Disease Drug

1.2 Crohn’s Disease Drug Segment by Type

1.2.1 Global Crohn’s Disease Drug Market Value Comparison by Type (2024-2030)

1.2.2 Aminosalicylates (5-ASA)

1.2.3 Corticosteroids

1.2.4 Immunomodulators

1.2.5 Antibiotics

1.3 Crohn’s Disease Drug Segment by Application

1.3.1 Global Crohn’s Disease Drug Market Value by Application: (2024-2030)

1.3.2 Achieving Remission (The Absence Of Symptoms)

1.3.3 Maintaining Remission (Prevention Of Flare-Ups)

1.3.4 Pediatric Crohn'S Disease

1.4 Global Crohn’s Disease Drug Market Size Estimates and Forecasts

1.4.1 Global Crohn’s Disease Drug Revenue 2019-2030

1.4.2 Global Crohn’s Disease Drug Sales 2019-2030

1.4.3 Global Crohn’s Disease Drug Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Crohn’s Disease Drug Market Competition by Manufacturers

2.1 Global Crohn’s Disease Drug Sales Market Share by Manufacturers (2019-2024)

2.2 Global Crohn’s Disease Drug Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Crohn’s Disease Drug Average Price by Manufacturers (2019-2024)

2.4 Global Crohn’s Disease Drug Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Crohn’s Disease Drug, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Crohn’s Disease Drug, Product Type & Application

2.7 Crohn’s Disease Drug Market Competitive Situation and Trends

2.7.1 Crohn’s Disease Drug Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Crohn’s Disease Drug Players Market Share by Revenue

2.7.3 Global Crohn’s Disease Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Crohn’s Disease Drug Retrospective Market Scenario by Region

3.1 Global Crohn’s Disease Drug Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Crohn’s Disease Drug Global Crohn’s Disease Drug Sales by Region: 2019-2030

3.2.1 Global Crohn’s Disease Drug Sales by Region: 2019-2024

3.2.2 Global Crohn’s Disease Drug Sales by Region: 2025-2030

3.3 Global Crohn’s Disease Drug Global Crohn’s Disease Drug Revenue by Region: 2019-2030

3.3.1 Global Crohn’s Disease Drug Revenue by Region: 2019-2024

3.3.2 Global Crohn’s Disease Drug Revenue by Region: 2025-2030

3.4 North America Crohn’s Disease Drug Market Facts & Figures by Country

3.4.1 North America Crohn’s Disease Drug Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Crohn’s Disease Drug Sales by Country (2019-2030)

3.4.3 North America Crohn’s Disease Drug Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Crohn’s Disease Drug Market Facts & Figures by Country

3.5.1 Europe Crohn’s Disease Drug Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Crohn’s Disease Drug Sales by Country (2019-2030)

3.5.3 Europe Crohn’s Disease Drug Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Crohn’s Disease Drug Market Facts & Figures by Country

3.6.1 Asia Pacific Crohn’s Disease Drug Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Crohn’s Disease Drug Sales by Country (2019-2030)

3.6.3 Asia Pacific Crohn’s Disease Drug Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Crohn’s Disease Drug Market Facts & Figures by Country

3.7.1 Latin America Crohn’s Disease Drug Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Crohn’s Disease Drug Sales by Country (2019-2030)

3.7.3 Latin America Crohn’s Disease Drug Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Crohn’s Disease Drug Market Facts & Figures by Country

3.8.1 Middle East and Africa Crohn’s Disease Drug Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Crohn’s Disease Drug Sales by Country (2019-2030)

3.8.3 Middle East and Africa Crohn’s Disease Drug Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Crohn’s Disease Drug Sales by Type (2019-2030)

4.1.1 Global Crohn’s Disease Drug Sales by Type (2019-2024)

4.1.2 Global Crohn’s Disease Drug Sales by Type (2025-2030)

4.1.3 Global Crohn’s Disease Drug Sales Market Share by Type (2019-2030)

4.2 Global Crohn’s Disease Drug Revenue by Type (2019-2030)

4.2.1 Global Crohn’s Disease Drug Revenue by Type (2019-2024)

4.2.2 Global Crohn’s Disease Drug Revenue by Type (2025-2030)

4.2.3 Global Crohn’s Disease Drug Revenue Market Share by Type (2019-2030)

4.3 Global Crohn’s Disease Drug Price by Type (2019-2030)

5 Segment by Application

5.1 Global Crohn’s Disease Drug Sales by Application (2019-2030)

5.1.1 Global Crohn’s Disease Drug Sales by Application (2019-2024)

5.1.2 Global Crohn’s Disease Drug Sales by Application (2025-2030)

5.1.3 Global Crohn’s Disease Drug Sales Market Share by Application (2019-2030)

5.2 Global Crohn’s Disease Drug Revenue by Application (2019-2030)

5.2.1 Global Crohn’s Disease Drug Revenue by Application (2019-2024)

5.2.2 Global Crohn’s Disease Drug Revenue by Application (2025-2030)

5.2.3 Global Crohn’s Disease Drug Revenue Market Share by Application (2019-2030)

5.3 Global Crohn’s Disease Drug Price by Application (2019-2030)

6 Key Companies Profiled

6.1 AbbVie

6.1.1 AbbVie Corporation Information

6.1.2 AbbVie Description and Business Overview

6.1.3 AbbVie Crohn’s Disease Drug Sales, Revenue and Gross Margin (2019-2024)

6.1.4 AbbVie Crohn’s Disease Drug Product Portfolio

6.1.5 AbbVie Recent Developments/Updates

6.2 Janssen Biotech

6.2.1 Janssen Biotech Corporation Information

6.2.2 Janssen Biotech Description and Business Overview

6.2.3 Janssen Biotech Crohn’s Disease Drug Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Janssen Biotech Crohn’s Disease Drug Product Portfolio

6.2.5 Janssen Biotech Recent Developments/Updates

6.3 Amgen

6.3.1 Amgen Corporation Information

6.3.2 Amgen Description and Business Overview

6.3.3 Amgen Crohn’s Disease Drug Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Amgen Crohn’s Disease Drug Product Portfolio

6.3.5 Amgen Recent Developments/Updates

6.4 Tillotts Pharma

6.4.1 Tillotts Pharma Corporation Information

6.4.2 Tillotts Pharma Description and Business Overview

6.4.3 Tillotts Pharma Crohn’s Disease Drug Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Tillotts Pharma Crohn’s Disease Drug Product Portfolio

6.4.5 Tillotts Pharma Recent Developments/Updates

6.5 Takeda Pharmaceuticals

6.5.1 Takeda Pharmaceuticals Corporation Information

6.5.2 Takeda Pharmaceuticals Description and Business Overview

6.5.3 Takeda Pharmaceuticals Crohn’s Disease Drug Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Takeda Pharmaceuticals Crohn’s Disease Drug Product Portfolio

6.5.5 Takeda Pharmaceuticals Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Crohn’s Disease Drug Industry Chain Analysis

7.2 Crohn’s Disease Drug Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Crohn’s Disease Drug Production Mode & Process

7.4 Crohn’s Disease Drug Sales and Marketing

7.4.1 Crohn’s Disease Drug Sales Channels

7.4.2 Crohn’s Disease Drug Distributors

7.5 Crohn’s Disease Drug Customers

8 Crohn’s Disease Drug Market Dynamics

8.1 Crohn’s Disease Drug Industry Trends

8.2 Crohn’s Disease Drug Market Drivers

8.3 Crohn’s Disease Drug Market Challenges

8.4 Crohn’s Disease Drug Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Takeda Pharmaceuticals

List of Tables

Table 1. Global Crohn’s Disease Drug Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Crohn’s Disease Drug Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Crohn’s Disease Drug Market Competitive Situation by Manufacturers in 2023

Table 4. Global Crohn’s Disease Drug Sales (K MT) of Key Manufacturers (2019-2024)

Table 5. Global Crohn’s Disease Drug Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Crohn’s Disease Drug Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Crohn’s Disease Drug Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Crohn’s Disease Drug Average Price (USD/MT) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Crohn’s Disease Drug, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Crohn’s Disease Drug, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Crohn’s Disease Drug, Product Type & Application

Table 12. Global Key Manufacturers of Crohn’s Disease Drug, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Crohn’s Disease Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Crohn’s Disease Drug as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Crohn’s Disease Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Crohn’s Disease Drug Sales by Region (2019-2024) & (K MT)

Table 18. Global Crohn’s Disease Drug Sales Market Share by Region (2019-2024)

Table 19. Global Crohn’s Disease Drug Sales by Region (2025-2030) & (K MT)

Table 20. Global Crohn’s Disease Drug Sales Market Share by Region (2025-2030)

Table 21. Global Crohn’s Disease Drug Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Crohn’s Disease Drug Revenue Market Share by Region (2019-2024)

Table 23. Global Crohn’s Disease Drug Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Crohn’s Disease Drug Revenue Market Share by Region (2025-2030)

Table 25. North America Crohn’s Disease Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Crohn’s Disease Drug Sales by Country (2019-2024) & (K MT)

Table 27. North America Crohn’s Disease Drug Sales by Country (2025-2030) & (K MT)

Table 28. North America Crohn’s Disease Drug Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Crohn’s Disease Drug Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Crohn’s Disease Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Crohn’s Disease Drug Sales by Country (2019-2024) & (K MT)

Table 32. Europe Crohn’s Disease Drug Sales by Country (2025-2030) & (K MT)

Table 33. Europe Crohn’s Disease Drug Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Crohn’s Disease Drug Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Crohn’s Disease Drug Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Crohn’s Disease Drug Sales by Region (2019-2024) & (K MT)

Table 37. Asia Pacific Crohn’s Disease Drug Sales by Region (2025-2030) & (K MT)

Table 38. Asia Pacific Crohn’s Disease Drug Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Crohn’s Disease Drug Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Crohn’s Disease Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Crohn’s Disease Drug Sales by Country (2019-2024) & (K MT)

Table 42. Latin America Crohn’s Disease Drug Sales by Country (2025-2030) & (K MT)

Table 43. Latin America Crohn’s Disease Drug Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Crohn’s Disease Drug Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Crohn’s Disease Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Crohn’s Disease Drug Sales by Country (2019-2024) & (K MT)

Table 47. Middle East & Africa Crohn’s Disease Drug Sales by Country (2025-2030) & (K MT)

Table 48. Middle East & Africa Crohn’s Disease Drug Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Crohn’s Disease Drug Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Crohn’s Disease Drug Sales (K MT) by Type (2019-2024)

Table 51. Global Crohn’s Disease Drug Sales (K MT) by Type (2025-2030)

Table 52. Global Crohn’s Disease Drug Sales Market Share by Type (2019-2024)

Table 53. Global Crohn’s Disease Drug Sales Market Share by Type (2025-2030)

Table 54. Global Crohn’s Disease Drug Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Crohn’s Disease Drug Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Crohn’s Disease Drug Revenue Market Share by Type (2019-2024)

Table 57. Global Crohn’s Disease Drug Revenue Market Share by Type (2025-2030)

Table 58. Global Crohn’s Disease Drug Price (USD/MT) by Type (2019-2024)

Table 59. Global Crohn’s Disease Drug Price (USD/MT) by Type (2025-2030)

Table 60. Global Crohn’s Disease Drug Sales (K MT) by Application (2019-2024)

Table 61. Global Crohn’s Disease Drug Sales (K MT) by Application (2025-2030)

Table 62. Global Crohn’s Disease Drug Sales Market Share by Application (2019-2024)

Table 63. Global Crohn’s Disease Drug Sales Market Share by Application (2025-2030)

Table 64. Global Crohn’s Disease Drug Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Crohn’s Disease Drug Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Crohn’s Disease Drug Revenue Market Share by Application (2019-2024)

Table 67. Global Crohn’s Disease Drug Revenue Market Share by Application (2025-2030)

Table 68. Global Crohn’s Disease Drug Price (USD/MT) by Application (2019-2024)

Table 69. Global Crohn’s Disease Drug Price (USD/MT) by Application (2025-2030)

Table 70. AbbVie Corporation Information

Table 71. AbbVie Description and Business Overview

Table 72. AbbVie Crohn’s Disease Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 73. AbbVie Crohn’s Disease Drug Product

Table 74. AbbVie Recent Developments/Updates

Table 75. Janssen Biotech Corporation Information

Table 76. Janssen Biotech Description and Business Overview

Table 77. Janssen Biotech Crohn’s Disease Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 78. Janssen Biotech Crohn’s Disease Drug Product

Table 79. Janssen Biotech Recent Developments/Updates

Table 80. Amgen Corporation Information

Table 81. Amgen Description and Business Overview

Table 82. Amgen Crohn’s Disease Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 83. Amgen Crohn’s Disease Drug Product

Table 84. Amgen Recent Developments/Updates

Table 85. Tillotts Pharma Corporation Information

Table 86. Tillotts Pharma Description and Business Overview

Table 87. Tillotts Pharma Crohn’s Disease Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 88. Tillotts Pharma Crohn’s Disease Drug Product

Table 89. Tillotts Pharma Recent Developments/Updates

Table 90. Takeda Pharmaceuticals Corporation Information

Table 91. Takeda Pharmaceuticals Description and Business Overview

Table 92. Takeda Pharmaceuticals Crohn’s Disease Drug Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 93. Takeda Pharmaceuticals Crohn’s Disease Drug Product

Table 94. Takeda Pharmaceuticals Recent Developments/Updates

Table 95. Key Raw Materials Lists

Table 96. Raw Materials Key Suppliers Lists

Table 97. Crohn’s Disease Drug Distributors List

Table 98. Crohn’s Disease Drug Customers List

Table 99. Crohn’s Disease Drug Market Trends

Table 100. Crohn’s Disease Drug Market Drivers

Table 101. Crohn’s Disease Drug Market Challenges

Table 102. Crohn’s Disease Drug Market Restraints

Table 103. Research Programs/Design for This Report

Table 104. Key Data Information from Secondary Sources

Table 105. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Crohn’s Disease Drug

Figure 2. Global Crohn’s Disease Drug Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Crohn’s Disease Drug Market Share by Type in 2023 & 2030

Figure 4. Aminosalicylates (5-ASA) Product Picture

Figure 5. Corticosteroids Product Picture

Figure 6. Immunomodulators Product Picture

Figure 7. Antibiotics Product Picture

Figure 8. Global Crohn’s Disease Drug Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 9. Global Crohn’s Disease Drug Market Share by Application in 2023 & 2030

Figure 10. Achieving Remission (The Absence Of Symptoms)

Figure 11. Maintaining Remission (Prevention Of Flare-Ups)

Figure 12. Pediatric Crohn'S Disease

Figure 13. Global Crohn’s Disease Drug Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Crohn’s Disease Drug Market Size (2019-2030) & (US$ Million)

Figure 15. Global Crohn’s Disease Drug Sales (2019-2030) & (K MT)

Figure 16. Global Crohn’s Disease Drug Average Price (USD/MT) & (2019-2030)

Figure 17. Crohn’s Disease Drug Report Years Considered

Figure 18. Crohn’s Disease Drug Sales Share by Manufacturers in 2023

Figure 19. Global Crohn’s Disease Drug Revenue Share by Manufacturers in 2023

Figure 20. The Global 5 and 10 Largest Crohn’s Disease Drug Players: Market Share by Revenue in 2023

Figure 21. Crohn’s Disease Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 22. Global Crohn’s Disease Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 23. North America Crohn’s Disease Drug Sales Market Share by Country (2019-2030)

Figure 24. North America Crohn’s Disease Drug Revenue Market Share by Country (2019-2030)

Figure 25. U.S. Crohn’s Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 26. Canada Crohn’s Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 27. Europe Crohn’s Disease Drug Sales Market Share by Country (2019-2030)

Figure 28. Europe Crohn’s Disease Drug Revenue Market Share by Country (2019-2030)

Figure 29. Germany Crohn’s Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. France Crohn’s Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. U.K. Crohn’s Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Italy Crohn’s Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Russia Crohn’s Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. Asia Pacific Crohn’s Disease Drug Sales Market Share by Region (2019-2030)

Figure 35. Asia Pacific Crohn’s Disease Drug Revenue Market Share by Region (2019-2030)

Figure 36. China Crohn’s Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. Japan Crohn’s Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. South Korea Crohn’s Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. India Crohn’s Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Australia Crohn’s Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Taiwan Crohn’s Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Indonesia Crohn’s Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Thailand Crohn’s Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Malaysia Crohn’s Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Philippines Crohn’s Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Latin America Crohn’s Disease Drug Sales Market Share by Country (2019-2030)

Figure 47. Latin America Crohn’s Disease Drug Revenue Market Share by Country (2019-2030)

Figure 48. Mexico Crohn’s Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Brazil Crohn’s Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Argentina Crohn’s Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Middle East & Africa Crohn’s Disease Drug Sales Market Share by Country (2019-2030)

Figure 52. Middle East & Africa Crohn’s Disease Drug Revenue Market Share by Country (2019-2030)

Figure 53. Turkey Crohn’s Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 54. Saudi Arabia Crohn’s Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 55. UAE Crohn’s Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 56. Global Sales Market Share of Crohn’s Disease Drug by Type (2019-2030)

Figure 57. Global Revenue Market Share of Crohn’s Disease Drug by Type (2019-2030)

Figure 58. Global Crohn’s Disease Drug Price (USD/MT) by Type (2019-2030)

Figure 59. Global Sales Market Share of Crohn’s Disease Drug by Application (2019-2030)

Figure 60. Global Revenue Market Share of Crohn’s Disease Drug by Application (2019-2030)

Figure 61. Global Crohn’s Disease Drug Price (USD/MT) by Application (2019-2030)

Figure 62. Crohn’s Disease Drug Value Chain

Figure 63. Crohn’s Disease Drug Production Process

Figure 64. Channels of Distribution (Direct Vs Distribution)

Figure 65. Distributors Profiles

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Inflammatory Bowel Disease IBD Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global IBD Ulcerative Colitis and Crohn s Disease Treatment Market Insights Forecast to 2030

Inflammatory Bowel Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Inflammatory Bowel Disease Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Ulcerative Colitis Medicine Market Research Report 2025

Global Ulcerative Colitis Immunology Drugs Market Research Report 2024

Global Still s Disease Treatment Market Research Report 2025

Chronic Intestinal Inflammation Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Autoimmune Diseases Treatment Market Research Report 2024

Global Ulcerative Colitis Treatment Options Market Research Report 2025

Global Diagnostic Guidewire Market Research Report 2024

Global Chronic Kidney Disease Drugs Market Research Report 2025

Global CGT Drugs Market Research Report 2025

Global Rare Disease Drug Market Research Report 2024

Super Generic Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Immune Drugs Market Insights Forecast to 2030

Pharmaceutical CRDMO Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Drug Discovery CRO Market Research Report 2025

Global Cholesterol Lowering Drugs Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions